Novavax
NVAX
#5751
Rank
$1.12 B
Marketcap
$6.91
Share price
0.73%
Change (1 day)
-16.75%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : $1.17 Billion USD

According to Novavax's latest financial reports the company's total assets are $1.17 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$1.56 B-13.19%
2023-12-31$1.79 B-20.42%
2022-12-31$2.25 B-12.34%
2021-12-31$2.57 B62.83%
2020-12-31$1.58 B814.96%
2019-12-31$0.17 B-16.84%
2018-12-31$0.20 B-31.25%
2017-12-31$0.30 B-23.28%
2016-12-31$0.39 B2.14%
2015-12-31$0.38 B39.87%
2014-12-31$0.27 B17.39%
2013-12-31$0.23 B129.74%
2012-12-31$0.10 B53.73%
2011-12-31$66.57 M-11.05%
2010-12-31$74.84 M-12.57%
2009-12-31$85.6 M11.72%
2008-12-31$76.62 M-16.07%
2007-12-31$91.29 M-25.1%
2006-12-31$0.12 B44.43%
2005-12-31$84.38 M8.19%
2004-12-31$77.99 M-7.33%
2003-12-31$84.15 M46.35%
2002-12-31$57.5 M-14.32%
2001-12-31$67.11 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
$0.23 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$3.49 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$1.46 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.44 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$114.45 B 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$208.73 B 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$107.28 B 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
$8.82 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$82.46 B 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
$0.64 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA